|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | ||||||
| Short-term investments | ||||||
| Prepaid expenses and other current assets | ||||||
| Total current assets | ||||||
| Operating lease right-of-use asset | ||||||
| Other assets | ||||||
| Total assets | ||||||
| Liabilities and Stockholders' Equity | ||||||
| Current liabilities: | ||||||
| Accounts payable | ||||||
| Accrued liabilities | ||||||
| Operating lease liability, current portion | ||||||
| Total current liabilities | ||||||
| Operating lease liability, net of current portion | ||||||
| Other long-term liabilities | ||||||
| Total liabilities | ||||||
| Convertible preferred stock, $0.00001 par value; no shares and 96,941,453 shares authorized at March 31, 2025 and December 31, 2024, respectively; no shares and 96,941,453 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively; liquidation preference of $0 and $129,135 at March 31, 2025 and December 31, 2024, respectively | ||||||
| Stockholders' equity | ||||||
| Preferred stock, $0.00001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||
| Common stock, $0.00001 par value; 490,000,000 shares authorized at June 30, 2026 and December 31, 2025; 21,884,158 and 21,815,353 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||
| Additional paid-in capital | ||||||
| Accumulated other comprehensive income | ||||||
| Accumulated deficit | ||||||
| Total stockholders' equity | ||||||
| Total liabilities and stockholders' equity |
Loading...
